Nonhuman Primate Core
Nonhuman Primate Core
批准号:
9041030
负责人:
Melissa Dawn Bauman
金额:
$33.63万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAnimal ModelArchivesBehaviorBehavior assessmentBehavioralBehavioral AssayBiological MarkersBiological ModelsBrainBrain DiseasesChildComplexCorpus striatum structureCuesDevelopmentDiseaseDopamineEnvironmentEnvironmental Risk FactorEpidemiologic StudiesEtiologyEvaluationExposure toFaceFailureFunctional disorderGene ExpressionGenesGenetic RiskGoalsGrantHumanImageImmuneImmune systemImpairmentInfectionLeadLinkMacacaMacaca mulattaMaternal BehaviorMeasuresMental HealthMental disordersModelingMolecularMonkeysMotorNational Institute of Mental HealthNeurodevelopmental DisorderNeuroimmunomodulationOutcomePathogenesisPathologyPathway interactionsPatientsPatternPhenotypePlayPoly I-CPoly ICLCPositioning AttributePositron-Emission TomographyPregnancyPrimatesPsychopathologyPsychotic DisordersResearchRiskRodentRodent ModelRoleSamplingSchizophreniaSelf-Injurious BehaviorSeriesSignal TransductionSocial DevelopmentStructureStudy modelsTimeTranslationsViralWorkbehavioral impairmentbrain behaviorbrain tissuecellular pathologyclinically relevantcohortdiagnostic biomarkergazehuman diseaseimmune activationimprovedinnovationinsightmolecular pathologyneurobehavioralneuroimagingneuroinflammationneuropathologynonhuman primatenovelnovel therapeutic interventionoffspringpatient populationpostnatalpregnantprenatalprenatal exposuresocial
中文摘要
总结:非人灵长类核心
英文摘要
SUMMARY: NONHUMAN PRIMATE CORE
There is a critical unmet need to develop increasingly sophisticated animal models that will provide insights in
the brain mechanisms that may underlie the development of schizophrenia (SZ) and inform the development of
novel therapeutic interventions for this illness. While the underlying causes of the illness remain unknown,
converging evidence suggests that SZ is a neurodevelopmental brain disease resulting from a combination of
genetic and environmental risk factors. Our group is using cross-species, complimentary approaches to
examine one potential etiology of SZ – changes in the prenatal immune environment that alter brain and
behavioral development of the offspring. Evidence from epidemiological studies has shown that exposure to a
variety of infections during pregnancy is associated with an increased risk of having a child later develop SZ.
Rodent models have played a critical role in establishing causal relationships between the activated maternal
immune system and aberrant brain and behavior development in the offspring. The long term objective of the
Nonhuman Primate (NHP) Core is to bridge the gap between human studies and rodent models, and evaluate
the disease relevance of maternal immune activation (MIA) in a model system more closely related to humans
– the rhesus monkey. To accomplish this objective, we will undertake three specific aims. First the NHP core
will sample and distribute archived brain tissue from an initial cohort of rhesus monkeys prenatally exposed to
MIA to Projects 1 and 2 to evaluate the cellular and molecular pathology underlying aberrant behaviors of MIA
offspring. Second, the NHP core will generate a new cohort of MIA and control macaque offspring needed to
carry out a highly integrated series of structural, functional and molecular neuroimaging studies in Projects 3
and 4. Finally, the NHP core will conduct a comprehensive assessment of the behavioral development of the
new cohort of MIA and control macaque offspring using novel measures that probe the core features of SZ.
This interconnected evaluation of brain and behavioral development of monkeys prenatally exposed to MIA will
provide further support for an animal model of SZ with high construct, face and predictive reliability. By
accomplishing these aims the NHP core will contribute important new insights into the effects of MIA and the
mechanisms by which it may contribute to the pathophysiology of SZ. If successful this will lead to the
development of novel targets for the development of diagnostic biomarkers and innovative treatments for SZ
and other neurodevelopmental disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alterations in primate brain development following prenatal immune challenge
-
批准号:10793198
-
项目类别:
-
资助金额:$78.56万
-
财政年份:2023
-
负责人:Melissa Dawn Bauman
-
依托单位:
Epigenetic Modifications in the Nonhuman Primate Model of Maternal Immune Activation
-
批准号:9807936
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2019
-
负责人:Melissa Dawn Bauman
-
依托单位:
Project 3: Neurodevelopment in an NHP MIA model
-
批准号:10214321
-
项目类别:
-
资助金额:$77.16万
-
财政年份:2015
-
负责人:Melissa Dawn Bauman
-
依托单位:
Project 3: Neurodevelopment in an NHP MIA model
-
批准号:10592310
-
项目类别:
-
资助金额:$114.57万
-
财政年份:2015
-
负责人:Melissa Dawn Bauman
-
依托单位:
Pre-clinical evaluation of oxytocin for ASD treatment discovery
-
批准号:8824009
-
项目类别:
-
资助金额:$24.49万
-
财政年份:2015
-
负责人:Melissa Dawn Bauman
-
依托单位:
Project 3: Neurodevelopment in an NHP MIA model
-
批准号:10378733
-
项目类别:
-
资助金额:$108.68万
-
财政年份:2015
-
负责人:Melissa Dawn Bauman
-
依托单位:
Translating paradigms from clinical populations to animal models of schizophrenia
-
批准号:8785048
-
项目类别:
-
资助金额:$7.76万
-
财政年份:2014
-
负责人:Melissa Dawn Bauman
-
依托单位:
Efficacy of a Novel Neuroprotective Compound in Nonhuman Primate
-
批准号:8428350
-
项目类别:
-
资助金额:$24.46万
-
财政年份:2012
-
负责人:Melissa Dawn Bauman
-
依托单位:
Efficacy of a Novel Neuroprotective Compound in Nonhuman Primate
-
批准号:8546460
-
项目类别:
-
资助金额:$18.66万
-
财政年份:2012
-
负责人:Melissa Dawn Bauman
-
依托单位:
Efficacy of a Novel Neuroprotective Compound in Nonhuman Primate
-
批准号:8904994
-
项目类别:
-
资助金额:$3.91万
-
财政年份:2012
-
负责人:Melissa Dawn Bauman
-
依托单位:
PRIMATE MODELS OF AUTISM
-
批准号:8357296
-
项目类别:
-
资助金额:$7.56万
-
财政年份:2011
-
负责人:Melissa Dawn Bauman
-
依托单位:
PRIMATE MODELS OF AUTISM
-
批准号:8172571
-
项目类别:
-
资助金额:$11.41万
-
财政年份:2010
-
负责人:Melissa Dawn Bauman
-
依托单位:
海外基金